Phase II trial of weekly docetaxel in second-line therapy for nonsmall cell lung carcinoma
Open Access
- 10 October 2001
- Vol. 92 (8) , 2158-2163
- https://doi.org/10.1002/1097-0142(20011015)92:8<2158::aid-cncr1558>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinomaCancer, 2000
- Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy RegimensJournal of Clinical Oncology, 2000
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyJournal of Clinical Oncology, 2000
- Docetaxel Administered on a Weekly Basis for Metastatic Breast CancerJournal of Clinical Oncology, 2000
- Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.Journal of Clinical Oncology, 1998